Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fidia Spa ( (IT:FDA) ) has provided an announcement.
Fidia S.p.A., based in Turin and listed on Euronext Milan, operates in the industrial technology sector and prepares its financial statements under IFRS standards. The company is subject to enhanced transparency rules by CONSOB, reflecting its delicate financial position and the regulator’s focus on its economic and capital-structure evolution.
Fidia has entered into an investment agreement with Global Growth Holding Limited for a 2026 convertible bond with warrants, aimed at strengthening its capital, although this instrument has not yet been executed. The company’s latest monthly disclosure under Italian securities law shows a weak liquidity position, with cash of €554,000 against current financial debt of €4.34 million as of 31 January 2026, highlighting a net current financial indebtedness of €3.79 million and ongoing regulatory scrutiny.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, operates in the industrial technology sector and prepares its financial statements under IFRS standards. The company is subject to enhanced transparency rules by CONSOB, reflecting its delicate financial position and the regulator’s focus on its economic and capital-structure evolution.
Fidia has entered into an investment agreement with Global Growth Holding Limited for a 2026 convertible bond with warrants, aimed at strengthening its capital, although this instrument has not yet been executed. The company’s latest monthly disclosure under Italian securities law shows a weak liquidity position, with cash of €554,000 against current financial debt of €4.34 million as of 31 January 2026, highlighting a net current financial indebtedness of €3.79 million and ongoing regulatory scrutiny.
Average Trading Volume: 964,804
Technical Sentiment Signal: Strong Sell
Current Market Cap: €3.3M
See more insights into FDA stock on TipRanks’ Stock Analysis page.